Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAXIMIZA: MPS vs MMF for Tacrolimus Reduction in Renal Transplant
NCT01056822Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started May 2010; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01056822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056822.